The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
CTC surveillance edges optical coloscopy for management of small polyps
November 30th 2008Using surveillance of 6 to 9-mm polyps with CT colonography instead of referring them for immediate colonoscopy and polypectomy provides a significant cost-effectiveness edge, according to a study presented Sunday.
PET/CT in prostate cancer influences staging, treatment strategy
November 30th 2008Prostate-specific antigen measurements are considered a useful organ-specific marker, but they are not necessarily an adequate tumor marker. PET/CT in combination with PSA levels can play a significant role in detecting and staging prostate cancer, according to two presentations Sunday at RSNA 2008.
Standardized chemoembolization protocol boosts liver cancer patient survival
November 30th 2008Results from the largest and longest trial of its kind suggest that patients with intermediate and advanced hepatocellular carcinomas who undergo systematic treatment with three chemotherapeutic agents and arterial embolization plus imaging follow-up have better survival rates than those who undergo nonstandardized chemoembolization regimes.
Nuclear imaging studies bounce back from 2006 decline
November 25th 2008Nearly 16 million U.S. patients underwent nuclear imaging procedures in 2007, according to a report by marketing research firm IMV Medical Information Division. The figure shows a 3% jump compared with the 15.2 million patients who had a nuclear medicine exam back in 2006.
RSNA preview: New session covers advancements made in Japan
November 25th 2008The RSNA will underscore the unique achievements of Japanese imaging researchers in “Japan Presents,” a presentation of seven scientific papers focusing on diagnostic radiology. On Monday, Dec. 1, each paper will be introduced with the Japanese spin on ideas and concepts.
Postelection moves signal healthcare reform action
November 21st 2008President-elect Barack Obama’s appointment of former Senate Majority Leader Tom Daschle to head the Department of Health and Human Services, combined with a commitment from insurers and a detailed plan from the chair of the powerful Senate Finance Committee, suggests strongly that healthcare reform will be a top priority for the new administration and the 111th Congress.
RSNA preview: Focus sessions explore imaging controversies
November 20th 2008You can tell by the titles of special focus sessions planned for the 2008 RSNA that program committee chair Dr. Robert M. Quencer sees an opportunity to use the sessions to examine tough issues affecting clinical imaging practice.
RSNA preview: CT coronary angiography, CT colonography gain widespread use
November 20th 2008Highlights of the 2008 RSNA meeting include discussions about the use of CT angiography as a noninvasive technique for diagnosing coronary artery disease and the replacement of standard optical colonoscopy with CT colonography to screen for colon cancer.
RSNA preview: Scientific sessions expand limits of imaging diagnosis and guidance
November 20th 2008There is nothing like a little momentum to help the RSNA organizers present the latest developments in imaging research in the meeting’s scientific sessions. Everyone associated with imaging sciences from Beijing to New York City understands that presenting research in Chicago is an essential requirement for membership in this unique community.
RSNA preview: CAD improves detection of pulmonary embolisms
November 20th 2008Computer-aided detection significantly improves the sensitivity of pulmonary embolism imaging, according to a study that will be presented at the 2008 RSNA meeting. Other studies show that specially developed CAD schemes can detect flat lesions that are often missed in CT colonography.
CT's impact in diagnosing appendicitis depends on clinical likelihood
October 23rd 2008Clinical experience shows that diagnostic CT reduces the incidence of negative appendectomies. Those skeptical about the application's safety, however, may find ammunition in a recent prospective study that suggests CT may be unnecessary when appendicitis is unlikely.
Europeans face potential Mo-99 supply nightmare; key nuclear reactor closed until February 2009
October 14th 2008The Nuclear Research and Consultancy Group (NRG) has announced that the High Flux Reactor in Petten, the Netherlands, will remain shut down until Feb. 16, 2009, raising the possibility of another four months of molybdenum-99 shortages for thousands of European nuclear imaging services.
European radioisotope supply woes continue
September 30th 2008The High Flux Reactor in Petten, the Netherlands, the primary source for the molybdenum-99 crucial to diagnostic nuclear imaging in Europe, will remain shut down until at least the end of November while officials devise a strategy to plug a gas leak.
Nuclear medicine dosing for kids varies widely
September 9th 2008A Boston Children's Hospital survey of 16 selected procedures at 13 pediatric hospitals in North America found a wide variation in radiopharmaceutical doses administered during nuclear medicine exams. The report reveals a need for consensus among nuclear physicians on appropriate doses for young patients.